Free Trial

Nurix Therapeutics (NRIX) Short Interest Ratio & Short Volume

→ Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad)
Free NRIX Stock Alerts
$16.57
-0.02 (-0.12%)
(As of 10:33 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Nurix Therapeutics Short Interest Data

Current Short Interest
6,900,000 shares
Previous Short Interest
7,040,000 shares
Change Vs. Previous Month
-1.99%
Dollar Volume Sold Short
$82.94 million
Short Interest Ratio
6.6 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
49,151,000 shares
Percentage of Shares Shorted
14.04%
Today's Trading Volume
72,403 shares
Average Trading Volume
936,213 shares
Today's Volume Vs. Average
8%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Nurix Therapeutics ?

Sign up to receive the latest short interest report for Nurix Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

NRIX Short Interest Over Time

NRIX Days to Cover Over Time

NRIX Percentage of Float Shorted Over Time

Nurix Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20246,900,000 shares $82.94 million -2.0%N/A6.6 $12.02
4/15/20247,040,000 shares $108.84 million +1.0%N/A7.2 $15.46
3/31/20246,970,000 shares $102.46 million +8.7%N/A8.7 $14.70
3/15/20246,410,000 shares $83.84 million -6.4%N/A7.9 $13.08
2/29/20246,850,000 shares $84.60 million -5.8%N/A8.5 $12.35
2/15/20247,270,000 shares $71.61 million -0.3%N/A9.2 $9.85
1/31/20247,290,000 shares $57.59 million +4.0%16.5%10 $7.90
1/15/20247,010,000 shares $65.68 million +6.4%15.9%9 $9.37
12/31/20236,590,000 shares $68.01 million -25.4%14.9%8.4 $10.32
12/15/20238,830,000 shares $80.18 million +6.0%20.0%12.4 $9.08
11/30/20238,330,000 shares $51.81 million +12.0%18.9%14.7 $6.22
11/15/20237,440,000 shares $47.99 million +4.4%16.9%14.7 $6.45
10/31/20237,130,000 shares $39.86 million +9.0%16.2%15.4 $5.59
10/15/20236,540,000 shares $41.66 million +5.3%14.8%17.2 $6.37
9/30/20236,210,000 shares $48.81 million -1.1%14.2%18.8 $7.86
9/15/20236,280,000 shares $55.64 million +12.5%14.3%20.2 $8.86
8/31/20235,580,000 shares $47.43 million -2.6%12.7%17.4 $8.50
8/15/20235,730,000 shares $51.46 million +2.9%13.1%20.2 $8.98
7/31/20235,570,000 shares $54.08 million +3.5%12.7%19.2 $9.71
7/15/20235,380,000 shares $52.51 million +3.5%12.4%17.3 $9.76
6/30/20235,200,000 shares $51.95 million -1.3%12.1%15.5 $9.99
6/15/20235,270,000 shares $58.55 million +1.4%12.3%15.1 $11.11
5/31/20235,200,000 shares $52.62 million -3.0%12.1%14.6 $10.12
5/15/20235,360,000 shares $58.21 million +3.1%12.7%14.3 $10.86
4/30/20235,200,000 shares $50.08 million +6.6%12.3%13.4 $9.63
4/15/20234,880,000 shares $59.63 million -0.8%11.6%12.8 $12.22
3/31/20234,920,000 shares $43.69 million +1.9%11.7%14.5 $8.88
3/15/20234,830,000 shares $45.06 million +5.9%11.5%14.2 $9.33
2/28/20234,560,000 shares $43.00 million -2.6%10.9%14.1 $9.43
2/15/20234,680,000 shares $48.44 million -0.4%11.1%14.2 $10.35
1/31/20234,700,000 shares $57.76 million -3.1%11.2%13.7 $12.29
1/15/20234,850,000 shares $56.55 million +2.8%11.6%13.5 $11.66
12/30/20224,720,000 shares $51.83 million +0.2%11.2%12.2 $10.98
12/15/20224,710,000 shares $56.10 million -0.4%11.2%11.8 $11.91
11/30/20224,730,000 shares $58.60 million -8.0%11.3%11.6 $12.39
11/15/20225,140,000 shares $72.99 million -8.9%12.2%13 $14.20
10/31/20225,640,000 shares $71.80 million +13.5%13.7%13.7 $12.73
10/15/20224,970,000 shares $54.02 million +0.8%12.6%11.9 $10.87
9/30/20224,930,000 shares $64.24 million +5.1%12.5%11.9 $13.03
9/15/20224,690,000 shares $76.78 million -0.4%11.9%10 $16.37
Warren Buffett's "mystery stock" (Ad)

WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.

This Wall Street millionaire just stepped forward with all the details, and how it could make some
8/31/20224,710,000 shares $74.09 million -7.8%12.0%9.8 $15.73
8/15/20225,110,000 shares $86.72 million -5.0%13.0%8.6 $16.97
7/31/20225,380,000 shares $85.86 million -0.7%13.8%9.1 $15.96
7/15/20225,420,000 shares $89.59 million -1.6%13.9%9.2 $16.53
6/30/20225,510,000 shares $69.81 million +7.6%14.8%9.5 $12.67
6/15/20225,120,000 shares $51.35 million +1.4%13.7%8.9 $10.03
5/31/20225,050,000 shares $50.95 million +19.7%13.5%9.2 $10.09
5/15/20224,220,000 shares $40.43 million +13.8%11.3%9.5 $9.58
4/30/20223,710,000 shares $41.07 million +7.2%10.2%8.5 $11.07
4/15/20223,460,000 shares $47.40 million +3.6%9.5%7.9 $13.70
3/31/20223,340,000 shares $46.79 million -13.3%9.2%7.4 $14.01
3/15/20223,850,000 shares $51.74 million +10.0%10.6%9.4 $13.44
2/28/20223,500,000 shares $56.60 million -13.6%9.6%10 $16.17
2/15/20224,050,000 shares $71.20 million +8.9%11.6%11.8 $17.58
1/31/20223,720,000 shares $69.27 million +7.8%11.1%11.4 $18.62
1/15/20223,450,000 shares $80.18 million +19.8%9.9%9.5 $23.24
12/31/20212,880,000 shares $83.38 million -2.0%8.3%8.7 $28.95
12/15/20212,940,000 shares $82.64 million -0.3%8.5%9.4 $28.11
11/30/20212,950,000 shares $85.02 million +2.4%8.5%8.8 $28.82
11/15/20212,880,000 shares $97.69 million -5.9%8.3%8.1 $33.92
10/29/20213,060,000 shares $102.36 million +1.7%9.1%9 $33.45
10/15/20213,010,000 shares $86.78 million -2.6%8.9%9.7 $28.83
9/30/20213,090,000 shares $92.58 million -1.0%9.2%7.9 $29.96
9/15/20213,120,000 shares $113.51 million -5.7%9.3%7.2 $36.38
8/31/20213,310,000 shares $106.55 million -5.2%9.9%7.6 $32.19
8/13/20213,490,000 shares $107.46 million -16.5%10.4%8.1 $30.79
7/30/20214,180,000 shares $128.49 million -9.5%14.4%9.3 $30.74
7/15/20214,620,000 shares $109.03 million -2.7%15.8%10.9 $23.60
6/30/20214,750,000 shares $126.02 million +10.0%16.3%12.5 $26.53
6/15/20214,320,000 shares $130.90 million -2.7%14.8%10.7 $30.30
5/28/20214,440,000 shares $123.88 million -7.1%15.2%9.9 $27.90
5/14/20214,780,000 shares $120.46 million -0.4%16.4%10.1 $25.20
4/30/20214,800,000 shares $166.75 million +8.6%19.1%9.6 $34.74
4/15/20214,420,000 shares $132.56 million +2.1%17.6%8.6 $29.99
3/31/20214,330,000 shares $122.63 million +60.4%19.2%8.5 $28.32
3/15/20212,700,000 shares $119.23 million +6.7%13.1%5.8 $44.16
2/26/20212,530,000 shares $84.55 million +7.7%16.7%7.1 $33.42
2/12/20212,350,000 shares $91.58 million +22.4%15.5%7.8 $38.97
1/29/20211,920,000 shares $72.06 million +5.5%9.5%7.2 $37.53
1/15/20211,820,000 shares $77.62 million No Change9.0%8.4 $42.65

NRIX Short Interest - Frequently Asked Questions

What is Nurix Therapeutics' current short interest?

Short interest is the volume of Nurix Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 6,900,000 shares of NRIX short. Learn More on Nurix Therapeutics' current short interest.

What is a good short interest ratio for Nurix Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NRIX shares currently have a short interest ratio of 7.0. Learn More on Nurix Therapeutics's short interest ratio.

Is Nurix Therapeutics' short interest increasing or decreasing?

Nurix Therapeutics saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 6,900,000 shares, a drop of 2.0% from the previous total of 7,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Nurix Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nurix Therapeutics: Phibro Animal Health Co. (2.76%), Aurinia Pharmaceuticals Inc. (8.11%), PureTech Health plc (0.02%), Sage Therapeutics, Inc. (16.60%), Nuvation Bio Inc. (2.51%), Wave Life Sciences Ltd. (2.27%), Cogent Biosciences, Inc. (12.59%), CureVac (4.79%), AnaptysBio, Inc. (18.06%), Praxis Precision Medicines, Inc. (5.06%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Nurix Therapeutics stock?

Short selling NRIX is an investing strategy that aims to generate trading profit from Nurix Therapeutics as its price is falling. NRIX shares are trading up $1.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Nurix Therapeutics?

A short squeeze for Nurix Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NRIX, which in turn drives the price of the stock up even further.

How often is Nurix Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRIX, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:NRIX) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
4 Cryptos BETTER than Bitcoin
True Market Insiders
Does this make you sick?
Allegiance Gold
Bill Gates is all about this tiny $2 stock
Timothy Sykes
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Shocking: One AI startup's revenue could surge 4,735%
Manward Press